Latinos are a dynamic, diverse, rising population. But cancer threatens the future health of the U.S. Latino population. This is why our Salud America! team at the Institute for Health Promotion Research (IHPR) at UT Health San Antonio created a new video, "Latino Cancer: ¿Sabía Usted? (Did You Know?)," to describe the state of Latino cancer disparities and highlight the inequities behind them. The video debuted at the 2022 Advancing the Science of Cancer in Latinos conference. "The conference helped focus on a key underlying issue – health equity. Health equity is where everyone has a fair, just opportunity to be their healthiest," said Dr. Amelie G. Ramirez, leader of the conference and director of Salud America! and the IHPR. "True change starts when we focus on solving ...
With 1 in 3 Latinos facing a cancer diagnosis in their lifetime, UT Health San Antonio is hosting the 2022 Advancing the Science of Cancer in Latinos in-person conference on Feb. 23-25 at the Westin Riverwalk, 420 W. Market St, in San Antonio, Texas. The biennial conference is expected to draw 200 researchers, oncologists, physicians, community leaders, and students for an open dialogue on research advancements and actions to translate basic research into clinical best practices, effective community interventions, system-change advocacy, and professional training to eliminate cancer disparities in Latinos. The first Advancing the Science of Cancer in Latinos conferences in 2018 and 2020 united 80 guest speakers and over 600 attendees from 25 states, from D.C and New York to ...
Living with a cognitive disease is difficult because of how it impacts you and those around you. It can create a stigma, which prevents people from seeking help. This stigma can be worse for Latinos, who face cultural barriers and are often affected by these disorders at a high rate. That’s why physicians like Dr. Gus Alva are trying to help Latinos heal from diseases like Parkinson’s. He teamed up with Acadia Pharmaceuticals and StoryCorps nonprofit for the “Yours, Truly” campaign, a bilingual effort to use multicultural storytelling to bring awareness to the non-motor symptoms of Parkinson’s disease. “This campaign is quite important because it really lends to the public an opportunity of being able through storytelling to convey some very important information ...
Omega 3 fatty acids are essential nutrients. Studies show omega 3 fish oil—which contains both docosahexaenoic acid (DHA) and eicosapentaenoic acid—may help lower blood pressure, slow the development of plaque in the arteries, and reduce the likelihood of heart attack and stroke. With the rising popularity of omega 3 fish oil supplements, researchers are conducting clinical trials to test their benefits for other health issues. This is why Dr. Andrew Brenner and his team at UT Health San Antonio are seeking volunteers for his clinical trial to explore of how omega 3 fatty acids can impact postmenopausal breast cancer patients. “Fish oil supplements with omega 3 fatty acids have been shown to stop or slow down the growth and development of breast cancer cells in ...
Declining kidney function is strongly linked to dementia, according to a 10-year study of older adults. This has negative implications for Latinos, who are not only at a high risk for Alzheimer’s and related dementias, but also for chronic kidney disease (CKD). “The kidneys and the brain, both being end organs, are thought to be susceptible to vascular damage due to similar anatomic and hemodynamic features,” according to the researchers. Learn more about what the study found on the link between poor kidney function and dementia, why Latinos are disproportionately affected by these diseases, and how we can help further the research of Latino chronic disease through clinical trials.
What Did the Study Find on Kidney Function and Dementia?
Researchers from the University ...
Dr. Amelie G. Ramirez, director of Salud America! at UT Health San Antonio and a leading health disparities researcher, has been selected for the 2022 AAHHE Outstanding Support of Hispanic Issues Award. The award recognizes an individual who has demonstrated outstanding accomplishments and support of the mission of the American Association of Hispanics in Higher Education, Inc. (AAHHE). AAHHE is an agent of change for improving education and enabling Latino students to fully participate in a diverse society. The organization works collaboratively with all sectors — education, business, industry, community and professional organizations — to meet the educational aspirations of a significantly increasing Latino population. Ramirez will receive the award at the 2022 AAHHE ...
A San Antonio woman in her 70s underwent South Texas’ first deep brain stimulation (DBS) surgery for Alzheimer’s — one of the first 300 surgeries of its kind in the world — at University Hospital on Nov. 5, 2021. UT Health San Antonio and clinical partner University Health are among 27 clinical trial sites worldwide evaluating the effectiveness of the DBS technique in a clinical trial to treat patients with mild Alzheimer’s disease. DBS is an established, nonpharmaceutical treatment that researchers hope could slow or even halt the progress of this devastating disease. Dr. Alexander Papanastassiou, associate professor of neurosurgery at UT Health San Antonio who sees University Health patients, implanted DBS electrodes during the operation. The surgery is minimally ...
Healthcare leaders say that the COVID-19 vaccine is the clearest path to end of the pandemic. However, vaccine misinformation spread on social media stands in the way. Many misinformation spreaders target Latino and Black communities, which have historical mistrust and skepticism in government. To combat this increasing threat, the Public Good Projects (PGP) and the New York State Health Foundation (NYSHF) created Project VCTR (Vaccine Communication Tracking & Response). Project VCTR helps track misinformation across different media sources to measure the public’s confidence in the vaccine. Currently, negative attitudes about the vaccine are declining after a strong rise in fall of 2021, according to the dashboard. They produce dashboards and track data affecting ...
By Robyn Towt
Breast Cancer Survivor in San Antonio My name is Robyn Towt. I am a three-time cancer survivor, most recently diagnosed with breast cancer in 2017 at the age of 44. I had stage one IDC that was found during my routine mammogram and ultrasound. I did not have any treatment, only a bilateral mastectomy and reconstruction with Mentor silicone breast implants. The implants caused an array of debilitating health issues, something that none of my doctors told me could happen. I had symptoms ranging from chronic migraines, rashes and extreme fatigue to debilitating insomnia, burning pain, heart palpitations, hair loss, difficulty breathing, difficulty swallowing and muscle pain. I had the implants removed after just four months and all of my symptoms completely ...